Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice in the Outpatient Clinical Settings in the Appalachian Highlands

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Maximum Age: 84
Healthy Volunteers: t
View:

• Patients aged 45-84 years of age (inclusive)

• Considered by health-care providers to be average risk for CRC as determined by USPSTF guidelines

• If a patient opts for blood-based test, they are able and willing to provide blood samples per protocol

• Ability to understand and the willingness to participate in the study

Locations
United States
Tennessee
Johnson City Medical Center
RECRUITING
Johnson City
Contact Information
Primary
Charlie Mayes, PhD
Charles.Mays@balladhealth.org
423-431-5654
Backup
Christy Adkins
christy.adkins@balladhealth.org
423-431-5667
Time Frame
Start Date: 2023-10-12
Estimated Completion Date: 2024-10-31
Participants
Target number of participants: 600
Treatments
No_intervention: Control
Patients judged to be at average risk of CRC will be engaged in a conversation about CRC risk factors and standard of care (SOC) screening options. Patients who express a desire to be screened using the SOC options will be considered part of the control group.
Experimental: Experimental
Patients judged to be at average risk of CRC will be engaged in a conversation about CRC risk factors and standard of care (SOC) screening options as well as the option to be screened with a blood-based test which is not currently standard of care. Patients who express a desire to be screened using the SOC options or the blood-based non-SOC option will be considered part of the experimental group.
Related Therapeutic Areas
Sponsors
Leads: Ballad Health

This content was sourced from clinicaltrials.gov